Adriana Mañas

9PUBLICATIONS
45CO-AUTHORS
Predictive and prognostic markersPeripheral nervous systemCancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteinsIndustrial molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 26, 2025
Dual lipid modulation overcomes ferroptosis resistance in high-risk neuroblastoma.

Ine Koeken, Magali Walravens, Roberto Fernández-Acosta

|Jun 25, 2025
Evaluation of TRPA1 as a Therapeutic Target in MYCN-Amplified Neuroblastoma.

Alexandra Seger, Dora Adamič, Erick Muciño Olmos

|Oct 17, 2024
Early evolutionary branching across spatial domains predisposes to clonal replacement under chemotherapy in neuroblastoma.

Jenny Karlsson, Hiroaki Yasui, Adriana Mañas

|Sep 11, 2024
Advances in the approaches used to repurpose drugs for neuroblastoma.

Marta Miera-Maluenda, María Pérez-Torres, Adriana Mañas

|Jun 28, 2023
Unconventional Source of Neurotoxic Protein Aggregation from Organelle Off-Target Bax∆2 in Alzheimer's Disease.

Qi Yao, Anne Caroline Mascarenhas Dos Santos, Huaiyuan Zhang

|Oct 28, 2022
Clinically relevant treatment of PDX models reveals patterns of neuroblastoma chemoresistance.

Adriana Mañas, Kristina Aaltonen, Natalie Andersson

Pageof 2

Frequent Collaborators

5 joint publications

Kristina Aaltonen

5 joint publications

Daniel Bexell

3 joint publications

Karin Hansson

2 joint publications

Katarzyna Radke